Hepatic ABCG5/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited

by Federica Basso, Lita A. Freeman, Carol Ko, Charles Joyce, Marcelo J. Amar, Robert D. Shamburek, Terese Tansey, Fairwell Thomas, Justina Wu, Beverly Paigen, Alan T. Remaley, Silvia Santamarina-Fojo, H. Bryan Brewer, Jr.
Published 2007-01-01

The effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory properties[S]

by Anna Schwendeman, Denis O. Sviridov, Wenmin Yuan, Yanhong Guo, Emily E. Morin, Yue Yuan, John Stonik, Lita Freeman, Alice Ossoli, Seth Thacker, Salena Killion, Milton Pryor, Y.Eugene Chen, Scott Turner, Alan T. Remaley
Published 2015-09-01

Comparison of Omega-3 Eicosapentaenoic Acid Versus Docosahexaenoic Acid-Rich Fish Oil Supplementation on Plasma Lipids and Lipoproteins in Normolipidemic Adults

by Zhi-Hong Yang, Marcelo Amar, Maureen Sampson, Amber B. Courville, Alexander V. Sorokin, Scott M. Gordon, Angel M. Aponte, Michael Stagliano, Martin P. Playford, Yi-Ping Fu, Shanna Yang, Nehal N. Mehta, Alan T. Remaley
Published 2020-03-01

Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia

by Chao Liu, Keith P. Gates, Longhou Fang, Marcelo J. Amar, Dina A. Schneider, Honglian Geng, Wei Huang, Jungsu Kim, Jennifer Pattison, Jian Zhang, Joseph L. Witztum, Alan T. Remaley, P. Duc Dong, Yury I. Miller
Published 2015-08-01

Sterol and lipid analyses identifies hypolipidemia and apolipoprotein disorders in autism associated with adaptive functioning deficits

by Elaine Tierney, Alan T. Remaley, Audrey Thurm, Leah R. Jager, Christopher A. Wassif, Lisa E. Kratz, Joan E. Bailey-Wilson, Irena Bukelis, Geeta Sarphare, Eun Sol Jung, Boudewien Brand, Kelly K. Noah, Forbes D. Porter
Published 2021-09-01

A thumbwheel mechanism for APOA1 activation of LCAT activity in HDL[S]

by Allison L. Cooke, Jamie Morris, John T. Melchior, Scott E. Street, W.Gray Jerome, Rong Huang, Andrew B. Herr, Loren E. Smith, Jere P. Segrest, Alan T. Remaley, Amy S. Shah, Thomas B. Thompson, W.Sean Davidson
Published 2018-01-01

Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway

by Alan T. Remaley, Fairwell Thomas, John A. Stonik, Steve J. Demosky, Samantha E. Bark, Edward B. Neufeld, Alexander V. Bocharov, Tatyana G. Vishnyakova, Amy P. Patterson, Thomas L. Eggerman, Silvia Santamarina-Fojo, H.Bryan Brewer
Published 2003-04-01

The extended lipid panel assay: a clinically-deployed high-throughput nuclear magnetic resonance method for the simultaneous measurement of lipids and Apolipoprotein B

by Erwin Garcia, Dennis W. Bennett, Margery A. Connelly, Elias J. Jeyarajah, Franklin C. Warf, Irina Shalaurova, Steven P. Matyus, Justyna Wolak-Dinsmore, David N. Oskardmay, Randolph M. Young, Maureen Sampson, Alan T. Remaley, James D. Otvos
Published 2020-12-01

Increased plasma cholesterol esterification by LCAT reduces diet-induced atherosclerosis in SR-BI knockout mice[S]

by Seth G. Thacker, Xavier Rousset, Safiya Esmail, Abdalrahman Zarzour, Xueting Jin, Heidi L. Collins, Maureen Sampson, John Stonik, Stephen Demosky, Daniela A. Malide, Lita Freeman, Boris L. Vaisman, Howard S. Kruth, Steven J. Adelman, Alan T. Remaley
Published 2015-07-01

Endothelial Expression of Scavenger Receptor Class B, Type I Protects against Development of Atherosclerosis in Mice

by Boris L. Vaisman, Tatyana G. Vishnyakova, Lita A. Freeman, Marcelo J. Amar, Stephen J. Demosky, Chengyu Liu, John A. Stonik, Maureen L. Sampson, Milton Pryor, Alexander V. Bocharov, Thomas L. Eggerman, Amy P. Patterson, Alan T. Remaley
Published 2015-01-01

Human SR-BII mediates SAA uptake and contributes to SAA pro-inflammatory signaling in vitro and in vivo.

by Irina N Baranova, Ana C P Souza, Alexander V Bocharov, Tatyana G Vishnyakova, Xuzhen Hu, Boris L Vaisman, Marcelo J Amar, Zhigang Chen, Alan T Remaley, Amy P Patterson, Peter S T Yuen, Robert A Star, Thomas L Eggerman
Published 2017-01-01

High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics

by Amisha V. Barochia, Elizabeth M. Gordon, Maryann Kaler, Rosemarie A. Cuento, Patricia Theard, Debbie M. Figueroa, Xianglan Yao, Nargues A. Weir, Maureen L. Sampson, Mario Stylianou, David F. Choy, Cecile T.J. Holweg, Alan T. Remaley, Stewart J. Levine
Published 2017-08-01

Lipoprotein X Causes Renal Disease in LCAT Deficiency.

by Alice Ossoli, Edward B Neufeld, Seth G Thacker, Boris Vaisman, Milton Pryor, Lita A Freeman, Christine A Brantner, Irina Baranova, Nicolás O Francone, Stephen J Demosky, Cecilia Vitali, Monica Locatelli, Mauro Abbate, Carlamaria Zoja, Guido Franceschini, Laura Calabresi, Alan T Remaley
Published 2016-01-01

Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings

by Kaare R. Norum, Alan T. Remaley, Helena E. Miettinen, Erik H. Strøm, Bruno E.P. Balbo, Carlos A.T.L. Sampaio, Ingrid Wiig, Jan Albert Kuivenhoven, Laura Calabresi, John J. Tesmer, Mingyue Zhou, Dominic S. Ng, Bjørn Skeie, Sotirios K. Karathanasis, Kelly A. Manthei, Kjetil Retterstøl
Published 2020-08-01

Plasma uric acid levels correlate with inflammation and disease severity in Malian children with Plasmodium falciparum malaria.

by Tatiana M Lopera-Mesa, Neida K Mita-Mendoza, Diana L van de Hoef, Saibou Doumbia, Drissa Konaté, Mory Doumbouya, Wenjuan Gu, Karim Traoré, Seidina A S Diakité, Alan T Remaley, Jennifer M Anderson, Ana Rodriguez, Michael P Fay, Carole A Long, Mahamadou Diakité, Rick M Fairhurst
Published 2012-01-01

Cholesterol transport between red blood cells and lipoproteins contributes to cholesterol metabolism in blood

by Ryunosuke Ohkawa, Hann Low, Nigora Mukhamedova, Ying Fu, Shao-Jui Lai, Mai Sasaoka, Ayuko Hara, Azusa Yamazaki, Takahiro Kameda, Yuna Horiuchi, Peter J. Meikle, Gerard Pernes, Graeme Lancaster, Michael Ditiatkovski, Paul Nestel, Boris Vaisman, Denis Sviridov, Andrew Murphy, Alan T. Remaley, Dmitri Sviridov, Minoru Tozuka
Published 2020-12-01

Phase 1 double-blind randomized safety trial of the Janus kinase inhibitor tofacitinib in systemic lupus erythematosus

by Sarfaraz A. Hasni, Sarthak Gupta, Michael Davis, Elaine Poncio, Yenealem Temesgen-Oyelakin, Philip M. Carlucci, Xinghao Wang, Mohammad Naqi, Martin P. Playford, Rishi R. Goel, Xiaobai Li, Ann J. Biehl, Isabel Ochoa-Navas, Zerai Manna, Yinghui Shi, Donald Thomas, Jinguo Chen, Angélique Biancotto, Richard Apps, Foo Cheung, Yuri Kotliarov, Ashley L. Babyak, Huizhi Zhou, Rongye Shi, Katie Stagliano, Wanxia Li Tsai, Laura Vian, Nathalia Gazaniga, Valentina Giudice, Shajia Lu, Stephen R. Brooks, Meggan MacKay, Peter Gregersen, Nehal N. Mehta, Alan T. Remaley, Betty Diamond, John J. O’ Shea, Massimo Gadina, Mariana J. Kaplan
Published 2021-06-01